Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant
Abstract LRRK2-related Parkinson’s disease (LRRK2-PD) is the most frequent form of monogenic PD worldwide, with important therapeutic opportunities, exemplified by the advancement in LRRK2 kinase inhibition studies/trials. However, many LRRK2 variants, especially those found in underrepresented popu...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-025-00884-6 |